4 most recent filings and news items mentioning BIAF. Updated every 60 seconds.
OfferingJun 18, 2026Positive
bioAffinity Technologies entered into a placement agency agreement with WallachBeth Capital to sell up to $3.2 million in securities comprising common stock at $0.80 per share and pre-funded warrants at $0.793. The offering provides capital for the company through a registered di
View filing at SEC.gov →
OtherJun 16, 2026Positive
bioAffinity Technologies partnered with Philips and 4DMedical to host a July 21, 2026 webinar on lung health screening for U.S. veterans, featuring CyPath Lung testing and mobile CT imaging. The initiative aims to improve early detection and access to lung cancer diagnostics for
View filing at SEC.gov →
OtherJun 2, 2026Positive
bioAffinity Technologies announced a June 16 webinar featuring physicians discussing real-world benefits of its noninvasive CyPath Lung test for early-stage lung cancer detection. The event highlights the test's clinical utility in reducing unnecessary invasive procedures and sup
View filing at SEC.gov →
RegulatoryMay 27, 2026Positive
bioAffinity Technologies announced notification of patent allowance from Mexico's Institute of Industrial Property for methods using flow cytometry and antibodies to detect lung cancer. The patent strengthens the company's global IP portfolio for its CyPath Lung diagnostic platfo
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.